Business Description
Kardigan Inc. is a Princeton-based biopharmaceutical company founded in 2023 that develops treatments for heart diseases, including conditions where the heart muscle weakens and leads to failure. The company uses an advanced research platform combining artificial intelligence, patient data, and heart-specific analysis to design better clinical trials and track how well treatments work. It also draws on a data and analytics system with FDA-cleared tools to strengthen its drug development efforts, and grows its treatment pipeline through licensing deals and acquisitions.
